Stelara 90MG/ML SYR 1S
Ended Awarded
- Contract number
- SPE2DX25FKVZA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 28, 2025, for Stelara 90mg/ml syringes valued at $16,249.95. The contract is firm fixed-price with a completion date of September 18, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, a $499.99 billion single-award vehicle valid through November 2026 that enables the agency to procure pharmaceutical products for military health facilities worldwide.
The Defense Logistics Agency, operating under the Department of Defense, utilizes this indefinite delivery contract to maintain a comprehensive pharmaceutical supply chain supporting military medical operations. Stelara is a biologic medication used to treat autoimmune conditions, and this delivery order represents one of numerous firm fixed-price pharmaceutical procurements issued through the DMS Pharmaceutical Group contract vehicle. The contractor's established position as a critical supplier in the federal pharmaceutical distribution network, combined with its comprehensive inventory of branded drugs, generics, biologics, and medical consumables, enables efficient fulfillment of urgent medication needs across Defense Department healthcare facilities.
Quick answers
Who was awarded contract SPE2DX25FKVZA?
SPE2DX25FKVZA was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 28, 2025.
How much is contract SPE2DX25FKVZA worth?
The government has obligated $16,250 on SPE2DX25FKVZA.
Is contract SPE2DX25FKVZA an order under another contract?
Yes. SPE2DX25FKVZA is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVZA competed?
The extent of competition for SPE2DX25FKVZA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award